Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics in thrombosis.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2010

Mousa Shaker A

Abstract excerpt

Inherited or acquired genetic abnormalities play a major role in thromboembolic complications. The goal of pharmacogenomics is to tailor medications to an individual's genetic makeup in order to improve the benefit-to-risk ratio. Significant findings have been documented showing the effect of certain genetic variations (e.g., in CYP2C9 and VKORC1) on the dose response to warfarin. Pharmacogenomic and genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Transport
Share to Enzymes
Share to VKORC1 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Thrombosis

Share to Warfarin

Source

Identifiers

PMID: 20617424
DOI: 10.1007/978-1-60761-803-4_12

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics in thrombosis.PMID 20617424Read ↗

Genetic variations and their influence on risk and treatment of venous thrombosis.Semantic proximity Read ↗

Pharmacogenomics and coagulation disorders.Semantic proximity Read ↗

Warfarin pharmacogenomics: recommendations with available patented clinical technologies.Semantic proximity Read ↗

Pharmacogenetics of antithrombotic drugs.Semantic proximity Read ↗

Dissecting the genetic determinants of hemostasis and thrombosis.Semantic proximity Read ↗

GENETIC DETERMINANTS OF THROMBOSIS.Semantic proximity Read ↗

The future prospects of pharmacogenetics in oral anticoagulation therapySemantic proximity Read ↗

Venous thromboembolic disease genetics: from variants to function.Semantic proximity Read ↗

The pharmocogenomics of warfarin: closing in on personalized medicine.Semantic proximity Read ↗

Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.Semantic proximity Read ↗

What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies.Semantic proximity Read ↗

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.